Pulmonary arterial hypertension in adults with congenital heart disease: markers of disease severity, management of advanced heart failure and transplantation

References

• Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2018;53:1801913.
   Web of Science ®Google Scholar
• Galiè N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation. 2006;114(1):48–54.
   PubMed Web of Science ®Google Scholar
• Dimopoulos K, Inuzuka R, Goletto S, et al. Improved survival among patients with eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation. 2010;121(1):20–25.
   PubMed Web of Science ®Google Scholar
• Hjortshøj CMS, Kempny A, Jensen AS, et al. Past and current cause-specific mortality in Eisenmenger syndrome. Eur Heart J. 2017;38(26):2060–2067.
   PubMed Web of Science ®Google Scholar
• Diller G-P, Kempny A, Inuzuka R, et al. Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experience. Heart Br Card Soc. 2014;100:1366–1372.
   PubMed Web of Science ®Google Scholar
• Galiè N, Humbert M, Vachiery JL, et al. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the european society of cardiology (esc) and the european respiratory society (ers)endorsed by: association for european paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT). Eur Heart J. 2015;37(1):67-119.
   Web of Science ®Google Scholar
• Dimopoulos K, Wort SJ, Gatzoulis MA. Pulmonary hypertension related to congenital heart disease: a call for action. Eur Heart J. 2014;35(11):691–700.
   PubMed Web of Science ®Google Scholar
• Dimopoulos K, Diller G-P, Koltsida E, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117(18):2320–2328.
   PubMed Web of Science ®Google Scholar
• Kempny A, Hjortshøj CS, Gu H, et al. Predictors of death in contemporary adult patients with eisenmenger syndrome: a multicenter study. Circulation. 2017;135(15):1432–1440.
   PubMed Web of Science ®Google Scholar
• Kempny A, Diller G-P, Alonso-Gonzalez R, et al. Hypoalbuminaemia predicts outcome in adult patients with congenital heart disease. Heart Br Card Soc. 2015;101:699–705.
   Google Scholar
• Martin-Garcia AC, Arachchillage DR, Kempny A, et al. Platelet count and mean platelet volume predict outcome in adults with Eisenmenger syndrome. Heart Br Card Soc. 2018;104(1):45-50.
   Google Scholar
• Oya H, Nagaya N, Satoh T, et al. Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome. Heart Br Card Soc. 2000;84(1):53–58.
   PubMed Web of Science ®Google Scholar
• Shiina Y, Toyoda T, Kawasoe Y, et al. The prevalence and risk factors for cholelithiasis and asymptomatic gallstones in adults with congenital heart disease. Int J Cardiol. 2011;152(2):171–176.
   PubMed Web of Science ®Google Scholar
• Van Loon RLE, Roofthooft MTR, Delhaas T, et al. Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies. Am J Cardiol. 2010;106(1):117–124.
   PubMed Web of Science ®Google Scholar
• Kula S, Canbeyli F, Atasayan V, et al. A retrospective study on children with pulmonary arterial hypertension: a single-center experience. Anatol J Cardiol. 2018;20:41–47.
   PubMed Web of Science ®Google Scholar
• Naeije R, Manes A. The right ventricle in pulmonary arterial hypertension. Eur Respir Rev. 2014;23(134):476–487.
   PubMedGoogle Scholar
• Dimopoulos K, Diller G-P, editors. Pulmonary Hypertension in Adult Congenital Heart Disease [Internet]. 2017. Springer International Publishing, United States. Cited 2020 Jul 8. Available from https://www.springer.com/gp/book/9783319460260
   Google Scholar
• Zhu N, Welch CL, Wang J, et al. Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease. Genome Med. 2018;10(1):56.
   PubMedGoogle Scholar
• Moceri P, Kempny A, Liodakis E, et al. Physiological differences between various types of Eisenmenger syndrome and relation to outcome. Int J Cardiol. 2015;179:455–460.
   PubMed Web of Science ®Google Scholar
• Hopkins WE. The remarkable right ventricle of patients with Eisenmenger syndrome. Coron Artery Dis. 2005;16(1):19–25.
   PubMed Web of Science ®Google Scholar
• Manes A, Palazzini M, Leci E, et al. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. Eur Heart J. 2014;35(11):716–724.
   PubMed Web of Science ®Google Scholar
• Alonso-Gonzalez R, Lopez-Guarch CJ, Subirana-Domenech MT, et al. Pulmonary hypertension and congenital heart disease: an insight from the REHAP national registry. Int J Cardiol. 2015;184:717–723.
   PubMed Web of Science ®Google Scholar
• Daliento L, Somerville J, Presbitero P, et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J. 1998;19:1845–1855.
   PubMed Web of Science ®Google Scholar
• Dimopoulos K, Diller G-P, Petraco R, et al. Hyponatraemia: a strong predictor of mortality in adults with congenital heart disease. Eur Heart J. 2010;31(5):595–601.
   PubMed Web of Science ®Google Scholar
• Diller G-P, Alonso-Gonzalez R, Kempny A, et al. B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy. Heart. 2012;98(9):736–742.
   PubMed Web of Science ®Google Scholar
• Van De Bruaene A, Delcroix M, Pasquet A, et al. Iron deficiency is associated with adverse outcome in Eisenmenger patients. Eur Heart J. 2011;32(22):2790–2799.
   PubMed Web of Science ®Google Scholar
• Weaver H, Tulloh R. Thrombocytopenia in pulmonary hypertension, does it predict survival? Eur Heart J Internet]. 2013 [cited 2021 May 21];34. Available from:. ; :. https://doi.org/10.1093/eurheartj/eht307.P318.
   Google Scholar
• Scognamiglio G, Kempny A, Price LC, et al. C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value. Heart Br Card Soc. 2014;100:1335–1341.
   PubMed Web of Science ®Google Scholar
• Ramjug S, Hussain N, Hurdman J, et al. Pulmonary arterial hypertension associated with congenital heart disease: comparison of clinical and anatomic–pathophysiologic classification. J Heart Lung Transplant. 2016;35(5):610–618.
   PubMed Web of Science ®Google Scholar
• Favoccia C, Kempny A, Yorke J, et al. EmPHasis-10 score for the assessment of quality of life in various types of pulmonary hypertension and its relation to outcome. Eur J Prev Cardiol. 2019;26(12):1338-1340.
   Google Scholar
• Moceri P, Dimopoulos K, Liodakis E, et al. Echocardiographic predictors of outcome in eisenmenger syndrome. Circulation. 2012;126(12):1461–1468.
   PubMed Web of Science ®Google Scholar
• Hascoët S, Baruteau A-E, Humbert M, et al. Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2017;36(4):386–398.
   PubMed Web of Science ®Google Scholar
• Kempny A, Dimopoulos K, Uebing A, et al. Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life–single centre experience and review of published data. Eur Heart J. 2012;33(11):1386–1396.
   PubMed Web of Science ®Google Scholar
• Kempny A, Dimopoulos K, Alonso-Gonzalez R, et al. Six-minute walk test distance and resting oxygen saturations but not functional class predict outcome in adult patients with Eisenmenger syndrome. Int J Cardiol. 2013;168(5):4784–4789.
   PubMed Web of Science ®Google Scholar
• Condliffe R, Clift P, Dimopoulos K, et al. Management dilemmas in pulmonary arterial hypertension associated with congenital heart disease. Pulm Circ. 2018;8(3):2045894018792501.
   Web of Science ®Google Scholar
• Broberg CS, Uebing A, Cuomo L, et al. Adult patients with Eisenmenger syndrome report flying safely on commercial airlines. Heart Br Card Soc. 2007;93(12):1599–1603.
   Google Scholar
• Habib G, Lancellotti P, Antunes MJ, et al. ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the european society of cardiology (ESC). Endorsed by: european association for cardio-thoracic surgery (eacts), the european association of nuclear medicine (EANM). Eur Heart J. 2015;36(44):3075-3128.
   Google Scholar
• Stout KK, Daniels CJ, Aboulhosn JA, et al. AHA/ACC guideline for the management of adults with congenital heart disease: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Circulation. 2018;2018(139):e698–e800.
   Google Scholar
• Baumgartner H, De Backer J, Babu-Narayan SV, et al. European Society of Cardiology (ESC) Guidelines for the management of adult congenital heart disease. the task force for the management of adult congenital heart disease of the ESC. Eur Heart J Internet]. 2020 [cited 2020 Nov 14];ehaa554. Available from. 2020.
   Google Scholar
• Tay ELW, Peset A, Papaphylactou M, et al. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome. Int J Cardiol. 2011;151(3):307–312.
   PubMed Web of Science ®Google Scholar
• Blanche C, Alonso-Gonzalez R, Uribarri A, et al. Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension. Int J Cardiol. 2018;267:79–83.
   PubMed Web of Science ®Google Scholar
• Budts W, Pieles GE, Roos-Hesselink JW, et al. Recommendations for participation in competitive sport in adolescent and adult athletes with Congenital Heart Disease (CHD): position statement of the Sports Cardiology & exercise section of the european association of preventive cardiology (EAPC), the European Society of Cardiology (ESC) working group on adult congenital heart disease and the sports cardiology, physical activity and prevention working group of the association for european paediatric and congenital cardiology (AEPC). Eur Heart J. 2020;41(43):4191-4199.
   Web of Science ®Google Scholar
• Ladouceur M, Benoit L, Radojevic J, et al. Pregnancy outcomes in patients with pulmonary arterial hypertension associated with congenital heart disease. Heart Br Card Soc. 2017;103:287–292.
   Google Scholar
• Bédard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J. 2009;30(3):256–265.
   PubMed Web of Science ®Google Scholar
• Li Q, Dimopoulos K, Liu T, et al. Peripartum outcomes in a large population of women with pulmonary arterial hypertension associated with congenital heart disease. Eur J Prev Cardiol. 2019;26(10):1067–1076.
   PubMed Web of Science ®Google Scholar
• Sliwa K, Baris L, Sinning C, et al. Pregnant women with uncorrected congenital heart disease: heart failure and mortality. JACC Heart Fail. 2019;8(2):100-110.
   Google Scholar
• Hemnes AR, Kiely DG, Cockrill BA, et al. Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute. Pulm Circ. 2015;5(3):435–465.
   PubMed Web of Science ®Google Scholar
• Drakopoulou M, Nashat H, Kempny A, et al. Arrhythmias in adult patients with congenital heart disease and pulmonary arterial hypertension. Heart Br Card Soc. 2018;104(23):1963-1969.
   Google Scholar
• Price LC, Dimopoulos K, Marino P, et al. The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension. Thorax. 2017;72(11):1035–1045.
   PubMed Web of Science ®Google Scholar
• Price LC, Martinez G, Brame A, et al. Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement. Br J Anaesth. 2021;126(4):774–790.
   PubMed Web of Science ®Google Scholar
• Constantine A, Dimopoulos K. Evaluating a strategy of PAH therapy pre-treatment in patients with atrial septal defects and pulmonary arterial hypertension to permit safe repair (“treat-and-repair”). Int J Cardiol. 2019;291:142–144.
   PubMed Web of Science ®Google Scholar
• Berger RMF, Beghetti M, Galiè N, et al. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger’s syndrome: a subgroup analysis. Int J Cardiol Internet]. 2009 [cited 2010 Apr 29]; Available from. http://www.ncbi.nlm.nih.gov/pubmed/19464064
   Web of Science ®Google Scholar
• Mukhopadhyay S, Nathani S, Yusuf J, et al. Clinical efficacy of phosphodiesterase-5 inhibitor tadalafil in Eisenmenger syndrome–a randomized, placebo-controlled, double-blind crossover study. Congenit Heart Dis. 2011;6(5):424–431.
   PubMed Web of Science ®Google Scholar
• Gatzoulis MA, Landzberg M, Beghetti M, et al. Evaluation of macitentan in patients with eisenmenger syndrome. Circulation. 2019;139(1):51–63.
   PubMed Web of Science ®Google Scholar
• Iversen K, Jensen AS, Jensen TV, et al. Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial. Eur Heart J. 2010;31(9):1124–1131.
   PubMed Web of Science ®Google Scholar
• D’Alto M, Constantine A, Balint OH, et al. The effects of parenteral prostacyclin therapy as add-on treatment to oral compounds in Eisenmenger syndrome. Eur Respir J Internet]. 2019 [cited 2019 Nov 23];54. Available from. ; :. https://erj.ersjournals.com/content/54/5/1901401
   Web of Science ®Google Scholar
• Fernandes SM, Newburger JW, Lang P, et al. Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology. Am J Cardiol. 2003;91(5):632–635.
   PubMed Web of Science ®Google Scholar
• Cha KS, Cho KI, Seo JS, et al. Effects of inhaled iloprost on exercise capacity, quality of life, and cardiac function in patients with pulmonary arterial hypertension secondary to congenital heart disease (the Eisenmenger syndrome) (from the EIGER Study). Am J Cardiol. 2013;112(11):1834–1839.
   PubMed Web of Science ®Google Scholar
• Yang SI, Chung WJ, Jung SH, et al. Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome. Pediatr Cardiol. 2012;33(5):744–748.
   PubMed Web of Science ®Google Scholar
• Nashat H, Kempny A, Harries C, et al. A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: a pilot study. Int J Cardiol. 2020;299:131–135.
   PubMed Web of Science ®Google Scholar
• Blissett S, Blusztein D, Mahadevan VS. Contemporary use of Selexipag in pulmonary arterial hypertension associated with congenital heart disease: a case series. Eur Heart J Case Rep. 2020;4(6):1–7
   PubMedGoogle Scholar
• Diller G-P, M-a K, Bauer UMM, et al. Current therapy and outcome of Eisenmenger syndrome: data of the german national register for congenital heart defects. Eur Heart J. 2016;37(18):1449–1455.
   PubMed Web of Science ®Google Scholar
• Hascoet S, Fournier E, Jaïs X, et al. Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: a French multicentre study. Arch Cardiovasc Dis. 2017;110(5):303–316.
   PubMed Web of Science ®Google Scholar
• Anca C, Riley David C, Matthew R, et al. Determinants of sudden cardiac death in adult patients with eisenmenger syndrome. J Am Heart Assoc. 2020;9:e014554.
   PubMed Web of Science ®Google Scholar
• Galiè N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353(20):2148–2157.
   PubMed Web of Science ®Google Scholar
• Jansa P, Pulido T. Macitentan in pulmonary arterial hypertension: a focus on combination therapy in the SERAPHIN Trial. Am J Cardiovasc Drugs Drugs Devices Interv. 2018;18:1–11.
   PubMed Web of Science ®Google Scholar
• Sitbon O, Channick R, Chin KM, et al. Selexipag for the treatment of pulmonary arterial hypertension. N Engl J Med. 2015;373(26):2522–2533.
   PubMed Web of Science ®Google Scholar
• Dimopoulos K, Condliffe R, Tulloh RMR, et al. Echocardiographic screening for pulmonary hypertension in adults with congenital heart disease. J Am Coll Cardiol. 2018;72(22):2778–2788.
   PubMed Web of Science ®Google Scholar
• Bradley EA, Ammash N, Martinez SC, et al. “Treat-to-close”: non-repairable ASD-PAH in the adult: results from the North American ASD-PAH (NAAP) multicenter registry. Int J Cardiol. 2019;291:127–133.
   PubMed Web of Science ®Google Scholar
• Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014–an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2015;34(1):1–15.
   PubMed Web of Science ®Google Scholar
• Adriaenssens T, Delcroix M, Van Deyk K, et al. Advanced therapy may delay the need for transplantation in patients with the Eisenmenger syndrome. Eur Heart J. 2006;27(12):1472–1477.
   PubMed Web of Science ®Google Scholar
• Khush KK, Cherikh WS, Chambers DC, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-fifth adult heart transplantation report—2018; focus theme: multiorgan transplantation. J Heart Lung Transplant. 2018;37(10):1155–1168.
   PubMedGoogle Scholar
• Yusen RD, Edwards LB, Dipchand AI, et al. The registry of the international society for heart and lung transplantation: thirty-third adult lung and heart–lung transplant report—2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant. 2016;35(10):1170–1184.
   PubMed Web of Science ®Google Scholar
• Hascoët S, Pontailler M, Le Pavec J, et al. Transplantation for pulmonary arterial hypertension with congenital heart disease: impact on outcomes of current therapeutic approach including a high-priority allocation program. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2021. https://doi.org/10.1111/ajt.16600.
   Google Scholar
• Hjortshøj CS, Gilljam T, Dellgren G, et al. Outcome after heart–lung or lung transplantation in patients with Eisenmenger syndrome. Heart. 2020;106(2):127–132.
   PubMed Web of Science ®Google Scholar
• Ross HJ, Law Y, Book WM, et al. Transplantation and mechanical circulatory support in congenital heart disease: a scientific statement from the american heart association. Circulation. 2016;133(8):802–820.
   PubMed Web of Science ®Google Scholar
• Ethics - Ethical Principles in the Allocation of Human Organs – OPTN. Internet. [cited 2021 May 6]. Available from: https://optn.transplant.hrsa.gov/resources/ethics/ethical-principles-in-the-allocation-of-human-organs/.
   Google Scholar
• Alshawabkeh LI, Hu N, Carter KD, et al. Wait-List Outcomes for Adults With Congenital Heart Disease Listed for Heart Transplantation in the U.S. J Am Coll Cardiol. 2016;68(9):908–917.
   PubMed Web of Science ®Google Scholar
• Reitz BA, Wallwork JL, Hunt SA, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med. 1982;306(10):557–564.
   PubMed Web of Science ®Google Scholar
• Griffith BP, Magliato KE. Heart-Lung Transplantation. Oper Tech Thorac Cardiovasc Surg. 1999;4(2):124–141
   Google Scholar
• McGregor CG, Jamieson SW, Baldwin JC, et al. Combined heart-lung transplantation for end-stage Eisenmenger’s syndrome. J Thorac Cardiovasc Surg. 1986;91(3):443–450.
   PubMed Web of Science ®Google Scholar
• Chambers DC, Cherikh WS, Harhay MO, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult lung and heart–lung transplantation report—2019; focus theme: donor and recipient size match. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2019;38(10):1042–1055.
   PubMedGoogle Scholar
• Katz WE, Gasior TA, Quinlan JJ, et al. Immediate effects of lung transplantation on right ventricular morphology and function in patients with variable degrees of pulmonary hypertension. J Am Coll Cardiol. 1996;27(2):384–391.
   PubMed Web of Science ®Google Scholar
• Kramer MR, Valantine HA, Marshall SE, et al. Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension. Am J Cardiol. 1994;73(7):494–500.
   PubMed Web of Science ®Google Scholar
• Fremes SE, Patterson GA, Williams WG, et al. Single lung transplantation and closure of patent ductus arteriosus for Eisenmenger’s syndrome. J Thorac Cardiovasc Surg. 1990;100(1):1–5.
   PubMed Web of Science ®Google Scholar
• Aeba R, Griffith BP, Hardesty RL, et al. Isolated lung transplantation for patients with Eisenmenger’s syndrome. Circulation. 1993;88:II452–455.
   PubMed Web of Science ®Google Scholar
• Stoica SC, McNeil KD, Perreas K, et al. Heart-lung transplantation for Eisenmenger syndrome: early and long-term results. Ann Thorac Surg. 2001;72(6):1887–1891.
   PubMed Web of Science ®Google Scholar
• Kearney K, Lau EM, Darley D, et al. Waitlist and post-transplant outcomes for eisenmenger syndrome: a comparison of transplant strategies. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2021;S1053-2498(21): 02276–2.
   Google Scholar
• Hascoet S, Le Pavec J, De Lemos A, et al. Outcome of heart-lung and double lung transplantation in pulmonary arterial hypertension due to congenital heart disease is related to the complexity of the defects. J Heart Lung Transplant. 2020;39(4):S510.
   Web of Science ®Google Scholar
• Chang SH, Smith DE, Moazami N, et al. Transplant operative considerations in pulmonary hypertension with severe right heart failure. Semin Thorac Cardiovasc Surg. 2020;32(4):1024–1029.
   PubMed Web of Science ®Google Scholar
• Sertic F, Han J, Diagne D, et al. Not all septal defects are equal: outcomes of bilateral lung transplant with cardiac defect repair vs combined heart-lung transplant in patients with eisenmenger syndrome in the united states. Chest. 2020;158(5):2097–2106.
   PubMed Web of Science ®Google Scholar
• Gazengel P, Le Pavec J, Mercier O, et al. Combined lung transplantation and percutaneous septal defect closure for end-stage atrial septal defect associated pulmonary arterial hypertension. Arch Cardiovasc Dis Suppl. 2020;12:173–174.
   Google Scholar
• Machuca TN, De Perrot M. Mechanical support for the failing right ventricle in patients with precapillary pulmonary hypertension. Circulation. 2015;132(6):526–536.
   PubMed Web of Science ®Google Scholar
• Hascoet S, Boet A, Roussin R, et al. Pumpless lung assist as a bridge to medical therapy in a teenager with pulmonary arterial hypertension and partial anomalous pulmonary venous return. Can J Cardiol. 2020;36(11):1831.e7–1831.e9.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy Y, Cooper LB, Parikh KS, et al. Pulmonary Hypertension in the Era of Mechanical Circulatory Support. ASAIO J Am Soc Artif Int Org 1992. 2016;62(5):505–512.
   Google Scholar
• MacGowan GA, Crossland DS, Hasan A, et al. Considerations for patients awaiting heart transplantation-Insights from the UK experience. J Thorac Dis. 2015;7:527–531.
   PubMed Web of Science ®Google Scholar
• Trivedi JR, Cheng A, Singh R, et al. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant. Ann Thorac Surg. 2014;98(3):830–834.
   PubMed Web of Science ®Google Scholar
• Peng E, O’Sullivan JJ, Griselli M, et al. Durable ventricular assist device support for failing systemic morphologic right ventricle: early results. Ann Thorac Surg. 2014;98(6):2122–2129.
   PubMed Web of Science ®Google Scholar
• Punnoose L, Burkhoff D, Rich S, et al. Right ventricular assist device in end-stage pulmonary arterial hypertension: insights from a computational model of the cardiovascular system. Prog Cardiovasc Dis. 2012;55(2):234–243.e2.
   PubMed Web of Science ®Google Scholar
• Klepetko W, Mayer E, Sandoval J, et al. Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12):73S–80S.
   PubMed Web of Science ®Google Scholar
• Haddad H, Elabbassi W, Moustafa S, et al. Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension. ASAIO J Am Soc Artif Int Org 1992. 2005;51(4):456–460.
   Google Scholar
• Rosenzweig EB, Chicotka S, Bacchetta M. Right ventricular assist device use in ventricular failure due to pulmonary arterial hypertension: lessons learned. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2016;35(10):1272–1274.
   PubMed Web of Science ®Google Scholar
• Ius F, Kuehn C, Tudorache I, et al. Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2012;144(6):1510–1516.
   PubMed Web of Science ®Google Scholar
• Hoechter DJ, Shen Y-M, Kammerer T, et al. Extracorporeal circulation during lung transplantation procedures: a meta-analysis. ASAIO J. 2017;63(5):551–561.
   PubMed Web of Science ®Google Scholar
• Hoetzenecker K, Schwarz S, Muckenhuber M, et al. Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantation. J Thorac Cardiovasc Surg. 2018;155(5):2193–2206.e3.
   PubMed Web of Science ®Google Scholar
• Hoetzenecker K, Benazzo A, Stork T, et al. Bilateral lung transplantation on intraoperative extracorporeal membrane oxygenator: an observational study. J Thorac Cardiovasc Surg. 2020;160(1):320–327.e1.
   PubMed Web of Science ®Google Scholar
• Yasuhiro S, Hanjay W, Bharathi L, et al. Evaluation of risk factors for heart-lung transplant recipient outcome. Circulation. 2019;140(15):1261–1272.
   PubMed Web of Science ®Google Scholar
• Constantine A, Condliffe R, Clift P, et al. Palliative care in pulmonary hypertension associated with congenital heart disease: systematic review and expert opinion. ESC Heart Fail Internet]. 2021; Available from. ;8(3):1901–1914.
   PubMed Web of Science ®Google Scholar
• Swetz KM, Shanafelt TD, Drozdowicz LB, et al. Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey. J Heart Lung Transplant. 2012;31:1102–1108.
   PubMed Web of Science ®Google Scholar
• Fenstad ER, Shanafelt TD, Sloan JA, et al. Physician attitudes toward palliative care for patients with pulmonary arterial hypertension: results of a cross-sectional survey. Pulm Circ. 2014;4(3):504–510.
   PubMed Web of Science ®Google Scholar
• Tobler D, Greutmann M, Colman JM, et al. End-of-life in adults with congenital heart disease: a call for early communication. Int J Cardiol. 2012;155(3):383–387.
   PubMed Web of Science ®Google Scholar
• Tobler D, Greutmann M, Colman JM, et al. Knowledge of and preference for advance care planning by adults with congenital heart disease. Am J Cardiol. 2012;109(12):1797–1800.
   PubMed Web of Science ®Google Scholar
• Steiner JM, Stout K, Soine L, et al. Perspectives on advance care planning and palliative care among adults with congenital heart disease. Congenit Heart Dis. 2019;14(3):403–409.
   PubMed Web of Science ®Google Scholar
• Greutmann M, Tobler D, Colman JM, et al. Facilitators of and barriers to advance care planning in adult congenital heart disease. Congenit Heart Dis. 2013;8(4):281–288.
   PubMed Web of Science ®Google Scholar
• Tulloh R, Dimopoulos K, Condliffe R, et al. Management of adults with congenital heart disease and pulmonary arterial hypertension in the UK: survey of current practice, unmet needs and expert commentary. Heart Lung Circ. 2018;27(8):1018–1027.
   PubMed Web of Science ®Google Scholar
• Schwerzmann M, Goossens E, Gallego P, et al. Recommendations for advance care planning in adults with congenital heart disease: a position paper from the ESC Working Group Of Adult Congenital Heart Disease, The Association Of Cardiovascular Nursing And Allied Professions (ACNAP), the European Association for Palliative Care (EAPC), and the international society for adult congenital heart disease (ISACHD). Eur Heart J. 2020;41:4200–4210.
   PubMed Web of Science ®Google Scholar
• Khirfan G, Tonelli AR, Ramsey J, et al. Palliative care in pulmonary arterial hypertension: an underutilised treatment. Eur Respir Rev. 2018;27(150):180069.
   Web of Science ®Google Scholar
• Proposed Congenital Heart Disease Standards and Service specifications. NHS England - Citizen Space [Internet]. [cited 2020 May 31]. Available from: https://www.engage.england.nhs.uk/consultation/congenital-heart-disease-standards/
   Google Scholar